Prosight Management »

Janux Therapeutics shares owned by Prosight Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $21M 865k 24.44
2025-06-30 $20M 854k 23.10
2025-03-31 $19M 690k 27.00
2024-12-31 $18M 330k 53.54
2024-09-30 $9.3M 205k 45.43